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In an era when specialization is the rule in all segments of medicine, it is not
surprising that most of the journals now being published represent specialty
interests. For example, no longer is there within immunology (itself a specialized
field) simply a Journal of Immunology, but in addition, Immunogenetics, Trans-
plantation, and within the past few months, Immunotherapy, to mention only a few.
Scientists attend fewer multidisciplinary meetings, preferring smaller meetings at-
tended by those expert in the same discipline. When submitting their "best" papers,
they often choose a specialty or subspecialty journal rather than one catering to
broader interests, in order to communicate with their closest confreres in preference
to interested nonspecialists.
In this atmosphere, it is worth asking whether a nonspecialtyjournal can exist as a
viable enterprise. The Yale Journal ofBiology and Medicine has endured despite a
variety ofadversities since its inception in 1928. While financial instability has been a
continuing universal affliction in publishing, attracting the best work in experimental
and clinical medicine to a general medical journal is a far greater challenge.
Symposia and lecture series on a single theme make interesting reading, but it is the
original paper that provides the most excitement to the reader, as well as to the
student editor (for this journal) who first reviews it. In thinking about the issue, it
seemed to me that there are at least two points worth emphasizing to prospective
contributors. First, there is often a large backlog oforiginal papers under review for
a large specialty journal, making the time between submission of the paper and
publication 6 to 10 months or longer, even ifonly minor revisions are required. Many
journals curtly reject perfectly acceptable papers on the basis of"inappropriateness
for the readership of thejournal" or "lack of space," often without commenting on
the virtues or shortcomings of the article itself. Thus, even if the paper is accepted,
and especially if it isn't, the frustrations for prospective authors with the specialty
journals are considerable. In contrast, the Yale Journal can publish most accepted
papers within 6 months of submission and can give a detailed critique and decision of
acceptability within 6 to 8 weeks.
Second, the majority of readers of a scientific paper seem to be those who see the
article in an index such as Current Contents or Index Medicus and then obtain a re-
print. Those who read the article and then request the reprint are a minority,judging
from informal graphs that several of my colleagues and I have plotted of number of
requests versus time after publication. These graphs show an initial peak of en-
thusiastic readers who write immediately after reading the paper in their copy ofthe
particular journal, then a much larger, broader peak beginning at the time of the
publication of Current Contents or an equivalent listing. Finally, there is the peak
some months later when Index Medicus is published or in early summer when book
chapters or reviews are written. In other words, a paper that is listed in the appro-
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priate indexes will receive considerable attention regardless of the magnitude of its
primary readership. It is thus important to note that the YaleJournal is listed in all
major indexes and abstract services.
If this seems like an attempt to attract first-rate papers, it is! As long as the Yale
Journal continues to pursue an uncompromising policy of critical review, with con-
sequent rejection of inadequate papers, it will remain a prestigious medium through
which to reach the scientific public. An investigator who wants to reach a broad
medical and scientific audience without sacrificing dissemination of his data, would
do well to submit his efforts here.
Clearly, the Yale Journal need not rely upon preclinical scientific articles, since
there is an abundance of clinical information at Yale and other medical institutions.
Medical, surgical, and pediatric ground rounds are frequently scholarly reviews of
pathophysiology and therapy, and clinical pathology conferences, still the mainstay
of the New England Journal ofMedicine, deserve a place in the Yale Journal, too.
Carefully documented case reports and more extensive clinical investigations can be
the scientific equal of experiments with rodents and are equally desirable for these
pages. We have also recently reinstituted coverage of events around the Yale
medical community, including abstracts of important talks by many visiting
scientists. A series of articles on medical aspects of ecology, such as the importance
of trees and marshlands in preventing poisoning by serving as "traps" for pollutants,
will begin in the fall. Another on comparative medicine, indicating the similarity of
naturally-occurring and experimentally-induced diseases of animals to human afflic-
tions, is also projected. Lest this cause anxiety about changing the "tone" ofthe Yale
Journal, one should review the contents of Volume I, 1928-1929, as I did recently.
Most of the articles were clinical investigations or descriptions of unusual cases, in-
terspersed with medical history, community health, and one article on "Colour Vi-
sion of Fish". Many of the "great names" at Yale were represented in its 391 pages
(October through July) including Trask, Stone, Hiscock, Harvey, Blake, d'Herelle,
Burr, and Cowgill, not to mention "Vernon William Lippard, ofthe fourth-year class,
... who was elected to Alpha Omega Alpha", as noted under Comments (Events).
The YaleJournal must continue to evolve as it has throughout its 48-year history,
in order to cope with changes in the medical environment. Yet, plus ca change, plus
c'est la me^me chose! The expanded faculty and student editorial staff and I hope to
foster the best features oftheJournal in order to maintain its viability. With the help
of the Yale medical community and scientists at our sister institutions, both as
contributors and subscribers, we hope to keep this honorably and determinedly un-
specialized journal of medical science afloat amidst the many otherjournals of ever-
narrowing scope.
316